Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI. [electronic resource]
- Oral diseases Oct 2011
- 670-6 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1601-0825
10.1111/j.1601-0825.2011.01821.x doi
Adolescent Age Factors Anemia, Aplastic--surgery Area Under Curve Busulfan--blood Cyclophosphamide--therapeutic use Dose Fractionation, Radiation Female Graft vs Host Disease--drug therapy Granulomatous Disease, Chronic--surgery Hematopoietic Stem Cell Transplantation--methods Humans Immunosuppressive Agents--blood Leukemia, Myelogenous, Chronic, BCR-ABL Positive--surgery Leukemia, Myeloid, Acute--surgery Longitudinal Studies Lymphohistiocytosis, Hemophagocytic--surgery Lymphoma, T-Cell--surgery Male Myelodysplastic Syndromes--surgery Precursor Cell Lymphoblastic Leukemia-Lymphoma--surgery Salivary Glands--drug effects Secretory Rate--drug effects Sex Factors Transplantation Conditioning--methods Transplantation, Homologous Whole-Body Irradiation